Literature DB >> 19088265

Hepatic flavin-containing monooxygenase gene regulation in different mouse inflammation models.

Jun Zhang1, Madhusudana R Chaluvadi, Rob Reddy, Meike S Motika, Terrilyn A Richardson, John R Cashman, Edward T Morgan.   

Abstract

The objective of the study was to investigate the regulation of hepatic flavin-containing monooxygenases (Fmo) Fmo1, Fmo3, Fmo4, and Fmo5 in three different mouse models of inflammation, including treatment with Citrobacter rodentium, lipopolysaccharide (LPS), and dextran sulfate sodium (DSS). Quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) was used to evaluate the steady-state mRNA levels for the various Fmo isoforms in these mouse models of inflammation during different treatment time courses. Fmo3 mRNA was most significantly down-regulated in C. rodentium-treated female mice. Fmo1, Fmo3, and Fmo5 mRNAs were also found to be down-regulated in LPS models of inflammation. The significant down-regulation of hepatic FMO3 protein during C. rodentium treatment was confirmed with Western blot analysis of liver microsomes from treated animals. Toll-like receptor (TLR) 4 is known to be responsible for LPS signaling in association with several proteins. To investigate whether TLR4 was responsible for regulation of Fmo genes in both LPS and C. rodentium animal models, Fmo mRNA levels in female wild-type (C3H/HeOuJ) and TLR4 mutant (C3H/HeJ) mice were compared in both inflammatory models by real-time RT-PCR. The results showed that Fmo3 down-regulation during C. rodentium infection is independent of TLR4. Whereas TLR4 is likely to play only a partial role in Fmo1 gene regulation in LPS-treated animals, our results show that the down-regulation of Fmo3 and Fmo5 in this model is TLR4-dependent. Unlike cytochrome P450 regulation measured in the same mouse strains, Fmo3 expression was largely refractory to down-regulation in the DSS model of inflammatory colitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19088265      PMCID: PMC2680514          DOI: 10.1124/dmd.108.025338

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  39 in total

1.  Role of nitric oxide in down-regulation of CYP2B1 protein, but not RNA, in primary cultures of rat hepatocytes.

Authors:  L Ferrari; N Peng; J R Halpert; E T Morgan
Journal:  Mol Pharmacol       Date:  2001-07       Impact factor: 4.436

Review 2.  The role of flavin-containing monooxygenases in drug metabolism and development.

Authors:  John R Cashman
Journal:  Curr Opin Drug Discov Devel       Date:  2003-07

Review 3.  Alteration of drug biotransformation and elimination during infection and inflammation.

Authors:  K W Renton
Journal:  Pharmacol Ther       Date:  2001 Nov-Dec       Impact factor: 12.310

4.  Regulation of flavin-containing monooxygenase 1 expression by ying yang 1 and hepatic nuclear factors 1 and 4.

Authors:  Z Luo; R N Hines
Journal:  Mol Pharmacol       Date:  2001-12       Impact factor: 4.436

5.  Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent.

Authors:  E Siewert; R Bort; R Kluge; P C Heinrich; J Castell; R Jover
Journal:  Hepatology       Date:  2000-07       Impact factor: 17.425

6.  Transcription factors C/EBP-alpha and HNF-1alpha are associated with decreased expression of liver-specific genes in sepsis.

Authors:  Charlotte A Haaxma; Patrick K Kim; Kenneth M Andrejko; Nichelle R Raj; Clifford S Deutschman
Journal:  Shock       Date:  2003-01       Impact factor: 3.454

7.  Regulation of hepatic cytochrome P450 expression in mice with intestinal or systemic infections of citrobacter rodentium.

Authors:  Madhusudana R Chaluvadi; Ryan D Kinloch; Beatrice A Nyagode; Terrilyn A Richardson; Malik J Raynor; Melanie Sherman; Leposava Antonovic; Henry W Strobel; Dirck L Dillehay; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2008-10-29       Impact factor: 3.922

8.  Genetic variability at the human FMO1 locus: significance of a basal promoter yin yang 1 element polymorphism (FMO1*6).

Authors:  Ronald N Hines; Zhaohui Luo; Kathleen A Hopp; Erwin T Cabacungan; Sevasti B Koukouritaki; D Gail McCarver
Journal:  J Pharmacol Exp Ther       Date:  2003-06-26       Impact factor: 4.030

9.  TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease.

Authors:  Madhusudana R Chaluvadi; Beatrice A Nyagode; Ryan D Kinloch; Edward T Morgan
Journal:  Biochem Pharmacol       Date:  2008-11-06       Impact factor: 5.858

10.  Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis.

Authors:  Yasuhiro Masubuchi; Toshiharu Horie
Journal:  Drug Metab Dispos       Date:  2004-04       Impact factor: 3.922

View more
  17 in total

1.  Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population.

Authors:  Makiko Shimizu; Charles K Allerston; Elizabeth A Shephard; Hiroshi Yamazaki; Ian R Phillips
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

Review 2.  Flavin-containing monooxygenases in aging and disease: Emerging roles for ancient enzymes.

Authors:  Ryan Rossner; Matt Kaeberlein; Scott F Leiser
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

3.  Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine.

Authors:  Suman Srinivasa; Kathleen V Fitch; Janet Lo; Hanane Kadar; Rachel Knight; Kimberly Wong; Suhny Abbara; Dominique Gauguier; Jacqueline Capeau; Franck Boccara; Steven K Grinspoon
Journal:  AIDS       Date:  2015-02-20       Impact factor: 4.177

4.  Selective role for tumor necrosis factor-α, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen.

Authors:  Ryan D Kinloch; Choon-Myung Lee; Nico van Rooijen; Edward T Morgan
Journal:  Biochem Pharmacol       Date:  2011-05-06       Impact factor: 5.858

5.  Transient massive trimethylaminuria associated with food protein-induced enterocolitis syndrome.

Authors:  Natalie B Miller; Avraham Beigelman; Elizabeth Utterson; Marwan Shinawi
Journal:  JIMD Rep       Date:  2013-07-03

Review 6.  Metaorganismal nutrient metabolism as a basis of cardiovascular disease.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  Curr Opin Lipidol       Date:  2014-02       Impact factor: 4.776

7.  Selective modulation of hepatic cytochrome P450 and flavin monooxygenase 3 expression during citrobacter rodentium infection in severe combined immune-deficient mice.

Authors:  Beatrice A Nyagode; William J Watkins; Ryan D Kinloch; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2012-06-27       Impact factor: 3.922

8.  Sulindac metabolism and synergy with tumor necrosis factor-alpha in a drug-inflammation interaction model of idiosyncratic liver injury.

Authors:  Wei Zou; Kevin M Beggs; Erica M Sparkenbaugh; A Daniel Jones; Husam S Younis; Robert A Roth; Patricia E Ganey
Journal:  J Pharmacol Exp Ther       Date:  2009-07-28       Impact factor: 4.030

9.  Pharmacokinetics of Morphine in Rats with Adjuvant-induced Arthritis.

Authors:  Yoshiaki Kimura; Mika Shibata; Mika Tamada; Noriyuki Ozaki; Kunizo Arai
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

10.  Downregulation of mouse hepatic CYP3A protein by 3-methylcholanthrene does not require cytochrome P450-dependent metabolism.

Authors:  Chunja Lee; Xinxin Ding; David S Riddick
Journal:  Drug Metab Dispos       Date:  2013-07-11       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.